U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C11H8NO4.Na
Molecular Weight 241.1753
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NIVIMEDONE SODIUM ANHYDROUS

SMILES

[Na+].CC1=C(C)C=C2C(=O)C(C(=O)C2=C1)=[N+]([O-])[O-]

InChI

InChIKey=KGLVEXSGYXXSOJ-UHFFFAOYSA-N
InChI=1S/C11H8NO4.Na/c1-5-3-7-8(4-6(5)2)11(14)9(10(7)13)12(15)16;/h3-4H,1-2H3;/q-1;+1

HIDE SMILES / InChI

Molecular Formula Na
Molecular Weight 22.9898
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C11H8NO4
Molecular Weight 218.1855
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Sodium nivimedone (BRL10833) is an orally administered anti-allergic agent with similar properties to DSCG. Nivimedone inhibited IgE-mediated passive cutaneous anaphylactic (PCA) reactions in the rat and the antigen-induced release of histamine from human lung passively sensitized with atopic serum. The pharmacological potency of sodium nivimedone when compared to DSCG was 42 times greater in the human lung system and approximately ten times greater in rat PCA. In addition, single doses of sodium nivimedone given by mouth inhibited antigen-induced bronchoconstriction in man.

Approval Year

PubMed

PubMed

TitleDatePubMed

Sample Use Guides

In Vivo Use Guide
Sodium nivimedone (BRL10833) given at an oral dose of 200 mg thrice daily, was compared, after a preliminary standardization week, with placebo in a 6-week double-blind cross-over trial.
Route of Administration: Oral
In Vitro Use Guide
Nivimedone (BRL10833) increases cAMP at a relatively high dose (10(-4) M) in guinea pig ileum.
Substance Class Chemical
Created
by admin
on Fri Dec 15 18:54:31 GMT 2023
Edited
by admin
on Fri Dec 15 18:54:31 GMT 2023
Record UNII
50HX07BAJU
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NIVIMEDONE SODIUM ANHYDROUS
Common Name English
5,6-DIMETHYL-2-ACI-NITRO-1,3-INDANDIONE SODIUM SALT
Common Name English
1H-INDENE-1,3(2H)-DIONE, 5,6-DIMETHYL-2-NITRO-, ION(1-), SODIUM
Common Name English
BRL-10833
Code English
1H-INDENE-1,3(2H)-DIONE, 5,6-DIMETHYL-2-NITRO-, ION(1-), SODIUM (1:1)
Common Name English
Code System Code Type Description
CAS
57441-90-4
Created by admin on Fri Dec 15 18:54:31 GMT 2023 , Edited by admin on Fri Dec 15 18:54:31 GMT 2023
PRIMARY
PUBCHEM
64752
Created by admin on Fri Dec 15 18:54:31 GMT 2023 , Edited by admin on Fri Dec 15 18:54:31 GMT 2023
PRIMARY
FDA UNII
50HX07BAJU
Created by admin on Fri Dec 15 18:54:31 GMT 2023 , Edited by admin on Fri Dec 15 18:54:31 GMT 2023
PRIMARY
Related Record Type Details
SOLVATE->ANHYDROUS
Related Record Type Details
ACTIVE MOIETY